Translation-X will be at Bio-Europe 2024 in Stockholm from November 4-6. Please join us at the Swiss Pavillion, meet our co-founder, Özgür Genç, and learn about our recent progress in precision therapies for autism spectrum disorders. #biotech #autism #autismspectrumdisorders #precisionmedicine #neuroscience
Translation-X’s Post
More Relevant Posts
-
#microbiome #autism #drug #discovery #study #neurodevelopmental #disorder #neuroscience, #RutgersHealth An analysis of how brains with different forms of autism develop has revealed common underlying mechanisms that may respond to existing medications. For the study, Rutgers Health researchers used induced pluripotent stem cells to transform the blood cells of people with both genetic and idiopathic autism spectrum disorder (ASD) into early brain cells called neural precursor cells. More in the article https://lnkd.in/dsiEhmma
-
My first paper was published earlier this month under the mentorship of Norah Al-Azzam, PhD. In our study, we uncovered that CHMP7 mislocalization—a known precursor of sporadic ALS—can be inhibited by upregulating SmD1 expression. Using eCLIP computational analysis, I identified that CHMP7 primarily binds to the CDS and 5′UTRs of several protein-coding genes. Gene Set Enrichment Analysis revealed that these genes are predominantly associated with splicing, providing the foundation for the rest of our experiments. This discovery highlights a potentially druggable step for ALS treatment. However, breakthroughs like this are only possible because of years of basic science that laid the groundwork. To develop treatments not just for ALS but for countless other diseases without effective treatments, sustained funding for organizations like the NIH and NSF is crucial. We must prioritize basic research even when the outcomes are uncertain.
Researchers at UC San Diego and colleagues have identified a key pathway leading to neurodegeneration in early stages of ALS, hinting at the potential for short-circuiting the progression of the fatal disease if diagnosed early. Learn more 🔗 https://bit.ly/3YNezdR #Neuroscience #StemCells #ALS
-
-
Neurophysiological rationale for Art Therapy
In our clinical research team’s latest conceptual review, the team reports on a neurophysiological rationale for art therapy as a therapeutic approach for individuals with post-traumatic stress disorder (PTSD). The framework presented aims to support larger-scale research and effective interventions. Read the review and learn about five art therapy factors that are proposed to align with neurophysiological evidence: https://lnkd.in/gvBuSUFf #ArtTherapy #PTSD #MentalHealthResearch #Neuroscience #CreativeForces Photo by Julia Zeltser
-
-
Online quarterly journal with 9 academicians, golden open access, international peer review, and high-quality publishing. Editor-in-Chief, Prof. Wei-dong Le.
Diving into the intricate role of tubular endoplasmic reticulum in axonal degeneration tied to neurodegenerative disorders! 🧠✨ Explore the latest insights and potential therapeutic avenues in our comprehensive review. #Neuroscience #ResearchReview Please check it at: https://lnkd.in/gsiFjiaa
-
Dive into the world of epilepsy diagnosis with the BBIT Test! Join us on Feb 12th for an exclusive video by Dr Pooja Jha, co-author of BBIT. Stay Tuned for insights and revelations! #EpilepsyAwareness #BBITTest Streaming at 10.30 AM. Watch on our LinkedIn page #EpilepsyDiagnosis #BBITTest #NeurologyInsights #HealthcareInnovation #Neuroscience #MedicalAdvancements #StayInformed #ExpertInsights #SaveTheDate #MedicalResearch #HealthTech #IqTest #BrainBasedIntelligenceTest
-
-
Can you spot the signs of Alzheimer’s disease? Explore our ConnectAD clinical case series to learn about the clinical presentation of Alzheimer’s disease and how to make an accurate diagnosis in the earliest stages. Get ConnectAD here: https://e.lilly/49GLC6F #Neuroscience
-
-
Watch our video to learn more about how Exazym® can help in the early detection of Alzheimer's disease. #SignalAmplification #Neuroscience #WorldAlzMonth #Cavidi #Exazym
Alzheimer's: New Detection Limits Open New Possibilities
-
Unlock deeper insights into #Parkinson's disease with advanced α-Synuclein detection tools. Discover how our ultrasensitive immunoassays enhance neurodegenerative research. http://ms.spr.ly/6040WHZ0m #Neuroscience #Immunoassays #ParkinsonsResearch
-
In a pivotal development, Eli Lilly's recent study highlights how adjusting donanemab dosing can effectively reduce ARIA-E in early Alzheimer's patients. Explore the transformative implications and potential global label updates that this brings. 🧬🌐 #Neuroscience #HealthCareAdvancement
-
-
🟦 New Molecular Signatures Found for #Alzheimer’s Disease Source: Mayo Clinic 🔷 Researchers identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer’s disease. They discovered altered communication between brain vascular cells mediated by #VEGFA and #SMAD3 molecules. These findings could lead to new diagnostic #biomarkers and treatment options for #Alzheimer’s. 🔷 The #blood-#brain barrier — a network of blood vessels and tissues that nurtures and #protects the #brain from harmful substances circulating in the blood — is disrupted in Alzheimer’s disease. 👉https://lnkd.in/eSdb6DPN #neurology #genetics #neuroscience #dementia #DLB #LDB #lewybodies #healthtech #digitalhealth #alzheimersdisease #futureofhealthcare Article and Design by Neuroscience News
-
